Upon AMPK re-expression, AMPK KO cells were significantly targeted by venetoclax, in favor of a positive contribution of AMPK expression in the early apoptotic response induced by Bcl-2 inhibition in AML (Figure 4C). This evidence concerns the gene BCL2 and acute myeloid leukemia.